LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF) today reported financial results for the second quarter ended June 30, 2025: “Herbalife is entering a pivotal new era. The beta release of our AI-assisted Pro2col™ app at our North America Extravaganza, with over 7,000 distributors joining this early access phase, marks a bold and powerful first step.” - Stephan Gratziani, CEO Highlights Second Quarter 2025 Net sales of $1.3 billion near midpoint of guidance range Down 1.7% vs. Q2 ‘24 Inc
Related Questions
What margin impact could the rollout and associated costs of the Pro2col™ app have on adjusted EBITDA?
How does Herbalife's Q2 performance compare to its competitors in the nutrition and weight‑loss industry?
How might the updated guidance influence analyst consensus, target price revisions, and overall market sentiment?
Will the participation of 7,000 distributors in the beta phase meaningfully expand the sales pipeline and market share?
What does net sales near the midpoint of guidance but down 1.7% YoY imply for the company's valuation and stock price?
Is the 1.7% YoY decline in net sales a temporary fluctuation or indicative of broader demand challenges?
How will the beta release of the AI‑assisted Pro2col™ app affect distributor engagement and future revenue growth?
Does the raised full‑year net‑sales and adjusted EBITDA guidance signal a stronger earnings outlook relative to market expectations?
Are there any operational or regulatory risks linked to the AI‑assisted product launch that could affect future results?
What factors could cause the raised guidance to be adjusted again in upcoming quarters, and how would that affect trading strategies?